enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.33M | -21.82M | -21.24M | -20.60M | -22.12M |
| Total Depreciation and Amortization | 509.00K | 528.00K | 540.00K | 549.00K | 551.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.94M | 4.16M | 4.27M | 4.22M | 4.28M |
| Change in Net Operating Assets | -422.00K | 290.00K | -277.00K | -814.00K | -18.00K |
| Cash from Operations | -17.31M | -16.84M | -16.71M | -16.64M | -17.30M |
| Capital Expenditure | -27.00K | -37.00K | -37.00K | -31.00K | -38.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.37M | 1.37M | -9.72M | -11.50M | -8.46M |
| Cash from Investing | 4.34M | 1.34M | -9.75M | -11.53M | -8.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.59M | 13.64M | 39.43M | 25.84M | 25.84M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.59M | 13.64M | 39.43M | 25.84M | 25.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 623.00K | -1.87M | 12.97M | -2.33M | 41.00K |